Original Articles |
From the Section of Health Policy and Administration, School of Public Health, Yale University School of Medicine, New Haven, Conn (P.S.K., A.J.E., H.M.K.); Department of Health Care Policy, Harvard Medical School and Department of Biostatistics, Harvard School of Public Health, Boston, Mass (S.T.N.); Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Conn (Z.L., E.E.D., K.R.B., J.A.M., Y.W., H.M.K.); Departments of Geriatrics and Adult Development and Medicine, Mount Sinai School of Medicine, New York, NY, and HSR&D Targeted Research Enhancement Program and Geriatrics Research, Education, and Clinical Center, James J. Peters Veterans Administration Medical Center, Bronx, NY (J.S.R.); Department of Emergency Medicine, Brigham and Womens Hospital and Department of Medicine, Harvard Medical School, Boston, Mass (J.D.S.); Baylor University Medical Hospital System, Dallas, Tex (B.D.S.); Performance Management, Yale–New Haven Health System, New Haven, Conn (S.M.B.); Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn (Y.-F.W., J.H., J.C., H.M.K.); Bayer Healthcare Pharmaceuticals, Wayne, NJ (J.J.F.); and Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn (H.M.K.). Drs Stauffer and Schuur were postdoctoral fellows in the Robert Wood Johnson Clinical Scholars Program at Yale University during the time the work was conducted. Jessica J. Federer was a Masters student at the Yale School of Public Health during the time the work was conducted.
Correspondence to Dr Harlan M. Krumholz, Yale University School of Medicine, Room I-456 SHM, 333 Cedar St, PO Box 208088, New Haven, CT 06520-8088. E-mail harlan.krumholz{at}yale.edu
Received June 26, 2008; accepted July 7, 2008.
| Abstract |
|---|
|
|
|---|
Methods and Results— We developed a hierarchical logistic regression model to calculate hospital risk-standardized 30-day all-cause readmission rates for patients hospitalized with heart failure. The model was derived with the use of Medicare claims data for a 2004 cohort and validated with the use of claims and medical record data. The unadjusted readmission rate was 23.6%. The final model included 37 variables, had discrimination ranging from 15% observed 30-day readmission rate in the lowest predictive decile to 37% in the upper decile, and had a c statistic of 0.60. The 25th and 75th percentiles of the risk-standardized readmission rates across 4669 hospitals were 23.1% and 24.0%, with 5th and 95th percentiles of 22.2% and 25.1%, respectively. The odds of all-cause readmission for a hospital 1 standard deviation above average was 1.30 times that of a hospital 1 standard deviation below average. State-level adjusted readmission rates developed with the use of the claims model are similar to rates produced for the same cohort with the use of a medical record model (correlation, 0.97; median difference, 0.06 percentage points).
Conclusions— This claims-based model of hospital risk-standardized readmission rates for heart failure patients produces estimates that may serve as surrogates for those derived from a medical record model.
Key Words: health policy heart failur equality of health care
| Introduction |
|---|
|
|
|---|
Editorial see p 9
Clinical Perspective p 37
This article presents a model, approved by the National Quality Forum,14 to estimate hospital-specific readmission rates for Medicare patients hospitalized with heart failure. We developed and validated the model with Medicare administrative claims data and determined whether estimates from the claims model were good surrogates for the results of a medical record model. We sought to ensure that this model had all the key attributes for publicly reported outcomes measures articulated by an American Heart Association Scientific Statement.15 This approach extends the work that produced National Quality Forum–approved models of 30-day mortality rates for acute myocardial infarction and heart failure, now publicly reported on Hospital Compare by the Centers for Medicare & Medicaid Services (CMS).16–18
| Methods |
|---|
|
|
|---|
Study Cohort
We identified hospitalizations of patients
65 years of age with a principal discharge diagnosis of heart failure as potential index heart failure hospitalizations (International Classification of Diseases, 9th Revision, Clinical Modification codes 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, or 428.xx). Because our focus was on readmission, we excluded hospitalizations during which the patient died or was transferred to another acute care facility.
To maximize our ability to risk-adjust and to identify readmissions, we restricted the cohort to patients enrolled in fee-for-service Medicare Parts A and B for 12 months before their heart failure hospitalization and who continued in fee-for-service for
30 days after their discharge.
Our unit of observation was a heart failure hospitalization. Additional heart failure hospitalizations that occurred within 30 days of discharge of an index hospitalization were classified as an outcome, ie, a readmission, and thus not defined as an index hospitalization.
Outcome
The primary outcome was 30-day readmission, defined as the occurrence of at least 1 hospitalization in any US acute care hospital for any cause within 30 days of discharge after an index hospitalization. We identified readmissions from the hospital claims data. Each readmission was attributed to the hospital that discharged the patient.
Candidate Variables
We developed candidate variables for the model from the claims codes using the aforementioned data sources. To assemble clinically coherent codes into candidate variables, we used the publicly available CMS hierarchical condition categories (CCs) to group codes into 189 CCs.20,21 A CC was indicated as present for a given patient if it was coded in any of the hospital inpatient, outpatient, or physician claims data sources in the prior 12 months, including the index admission. Additional candidate variables included 2 demographic variables and procedure codes relevant to heart failure readmission risk. A physician team identified candidate variables and differentiated CC variables that when coded as secondary diagnosis codes during the index hospitalization could represent either comorbid conditions on admission or complications of care (eg, urinary tract infection). To avoid including potential complications as comorbidities, we did not code them as risk factors if they appeared only as secondary diagnosis codes for the index hospitalization and not on claims in the prior year.
Model Derivation
A physician team (H.M.K., J.S.R., B.D.S., S.M.B., E.E.D.) selected risk factors for the final model on the basis of their statistical association with and clinical relevance to readmission, with reference to prior research.13 Additional details are provided in the Statistical Appendix in the online-only Data Supplement.
For the derivation of the administrative claims model, we randomly sampled half of the 2004 hospitalizations that met inclusion criteria. We conducted analyses of model performance by using a generalized linear model with a logit link function. To assess model performance at the patient level, we calculated the area under the receiver operating characteristic curve (AUC), explained variation as measured by the generalized R2 statistic, and calculated the observed readmission rates in the lowest and highest deciles on the basis of predicted readmission probabilities.23 We also compared performance with a null model, a model that adjusted for age and sex, and a model that included all of the candidate variables.
Risk-Standardized Readmission Rate
Given the clustering of admissions within hospitals and that hospitals were our unit of inference, we estimated risk-standardized readmission rates by using hierarchical generalized linear models.24 This modeling strategy accounts for within-hospital correlation of the observed readmission rates and reflects our assumption that after adjustment for patient risk and sampling variability, the remaining variation is due to hospital quality.
We next calculated risk-standardized hospital-specific readmission rates. These rates are obtained as the ratio of the number of "predicted" to "expected" readmissions, multiplied by the national unadjusted rate. The predicted number of readmissions in each hospital is estimated given its own patient mix and with its own hospital-specific intercept. The expected number of readmissions in each hospital is estimated with its own patient mix and the average hospital-specific intercept based on all hospitals in our sample. (Additional information is available in the Statistical Appendix in the online-only Data Supplement.) This is a form of indirect standardization.
Model Validation
Administrative Claims
We compared the model performance in the derivation sample with its performance in the remaining half of the 2004 claims data and, separately, with the 2003 claims data. The model was recalibrated in each validation set. We calculated indices that quantify overfitting for each validation data set, each time calculating a risk score using the regression estimates from our derivation model.23 A risk score coefficient that is much different from 1 and an intercept different from 0 are indicative of overfitting. We also examined whether model performance varied for important subgroups of patients: older patient age, sex, race/ethnicity, and urban/rural hospital.
Medical Record Model Validation
We developed a separate medical record model of readmission risk on the basis of NHF data (see Statistical Appendix in the online-only Data Supplement). We also linked the patients in the NHF cohort to their Medicare claims data, including claims from 1 year before the index hospitalization, so that we could calculate the risk-standardized state readmission rates in this cohort separately using medical record and claims data models. We conducted this analysis at the state level, for the 50 states plus the District of Columbia and Puerto Rico, because medical record data were only available in sufficient numbers to perform a state-level comparison. To examine the relationship between the risk-standardized rates obtained from medical record and administrative data models, we estimated a linear regression model describing the association between the 2 rates, weighting each state by the number of index hospitalizations, and calculated the intercept and the slope of this equation. A slope close to 1 and an intercept close to 0 would provide evidence that the risk-standardized state readmission rates from the medical record and claims models were similar. We also calculated the difference between the state risk-standardized readmission rates from the 2 models.
Analyses were conducted with the use of SAS version 9.1.3 (SAS Institute Inc, Cary, NC). Models were fitted separately for the NHF cohort and the 2004 cohort. We estimated the hierarchical models using the GLIMMIX procedure in SAS. The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
The authors had full access to the data and take responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
|
|
|
Medical Record Validation
Initial NHF data contained 78 882 hospitalization records. The final NHF validation sample included 64 329 hospitalizations from 4437 hospitals after exclusions were applied for age <65 years (8.3% of initial sample), in-hospital death (5.1%), transfer to another acute care facility (0.4%), incomplete information in the 12 months before admission (2.7%), incomplete 30-day readmission information (4.1%), and heart failure hospitalizations within 30 days of prior index hospitalizations (1.6%). The crude 30-day readmission rate was 23.7%.
In 6.8% of admissions, the patient died within the 30 days after discharge. In 4.1% of admissions, the patient died without being readmitted, and in 2.7% of admissions the patient was readmitted and died within the 30 days after discharge. The readmission rate was 39.6% among the 6.8% of admissions in which the patient died within 30 days compared with 22.5% for admissions in which patients survived 30 days.
The medical record comparison model included 30 variables (Table 4). In the medical record model, the AUC was 0.58, and the observed readmission rate ranged from 16% in the lowest predicted decile to 34% in the highest (Table 5). In the same cohort of 64 329 hospitalizations, the administrative model had an AUC of 0.61 and observed readmission rates ranging from 15% in the lowest predicted decile to 38% in the highest predicted decile.
|
|
|
85 years of age (0.58), and patients <85 years of age (0.61).
|
| Discussion |
|---|
|
|
|---|
Readmission after a hospitalization for heart failure is an important target for quality improvement. Heart failure accounts for
800 000 hospitalizations of Medicare fee-for-service patients annually. The risk of readmission is remarkably high within even a short time after discharge. Our study shows that 1 in 4 patients returns to the hospital within 30 days. Many studies have demonstrated the effectiveness of in-hospital and postdischarge interventions in reducing the risk of readmission, suggesting that hospitals and their partners have the ability to lower readmission rates.5–7,9–12,25 A 25% reduction in the readmission rate (ie, from 23.6% to 17.7%) could result in
50 000 fewer readmissions annually. Incentives for hospitals to reduce readmission rates are currently limited. In fact, hospitals that reduce readmissions could lower their Medicare revenues. Even institutions that participated in studies of successful interventions to reduce readmission often abandoned them soon after the study was over.26 Measuring readmission could promote sustained efforts to reduce readmission rates.
This model is consistent with the American Heart Association standards for models suitable for public reporting of outcomes in that it is transparent, excludes potential complications, uses an analysis appropriate for the organization of the data, and is validated against clinical data.15 It is patient oriented in that it includes readmissions to any acute care hospital, not just the discharging hospital, and minimizes the incentives for gaming readmission etiology as being unrelated to the index heart failure hospitalization. Inpatient and outpatient comorbidity information from the year before the index hospitalization captures the patients clinical conditions. The hierarchical model takes into account the structure of the data, with discharges clustered within hospitals, isolates variations due to quality differences, and accommodates hospitals with small volumes by appropriately reflecting their limited data in the estimates.
The agreement between the estimates from the claims model and from the medical record model suggests that despite the known limitations of administrative codes, the proposed model can stand in place of a model with more detailed clinical information for hospital-level profiling. The AUC and the explained variation of the model are modest, but the use of the model is to profile hospital performance on the basis of patient status at admission, not to develop a model with the best ability to predict outcomes for individual patients. In addition, the performance at the patient level is consistent with previously published models developed to predict readmission after a heart failure hospitalization, which also show modest c statistics for models based on administrative27 and medical record28 data. Furthermore, we excluded covariates that we would not want to adjust for in a quality measure, such as potential complications, patient race and socioeconomic status, and discharge disposition (eg, discharge to a skilled nursing facility). These characteristics may be associated with readmission and thus could increase the model performance to predict patient readmissions.13,29 However, they may reflect quality or system factors that should not be included in an adjustment that seeks to control for patient clinical characteristics while illuminating important quality differences.
Discrimination is lower in the heart failure readmission administrative and medical record models than in the heart failure mortality models.17 The risk of readmission may be much more dependent on the quality-of-care and system characteristics than on patient severity and comorbidity characteristics. The readiness for discharge, the proper medications, and the proper transition to the outpatient setting may be even more important for readmission than death. Intervention studies underscore this potential, finding substantial decreases in readmissions.5–7,9–12,25 Furthermore, some heart failure admissions may be discretionary, with higher rates in geographic areas with a greater supply of hospital beds.29
The approach has several limitations. The approach to calculating risk-standardized readmission rates is only validated with Medicare data. However,
75% of the patients hospitalized with heart failure are
65 years of age.30 In addition, we were unable to test the model with a Medicare managed care population because data are not currently available on those patients. Furthermore, the chart validation was conducted by state-level analysis because sample size was insufficient for hospital-level analysis. In addition, our modeling approach does not account for within-patient correlation of multiple index heart failure hospitalizations per patient because of computational limitations. However, a relatively small share of patients (9.1%) had multiple index heart failure hospitalizations. Although it is important to include all admissions for these patients so that hospital efforts to reduce readmissions among patients with multiple heart failure hospitalizations are fully reflected in the measure, we may have overstated the precision of individual covariates association with the risk of readmission. Furthermore, although not every readmission may be preventable, the all-cause readmission outcome minimizes incentives for gaming and best captures outcomes that are important to patients and amenable to quality improvement because interventions have generally shown reductions in non–heart failure as well as heart failure readmissions.
Finally, our approach focuses on 30-day readmission and not death. If a patient died within 30 days after discharge without a readmission, we coded the outcome as no readmission. We recognize that this has the effect of counting such a death as a "no event" readmission outcome. In addition, such patients have a shorter length of follow-up during which they are eligible to experience the readmission outcome. This approach is thus intended to be used in conjunction with the publicly reported heart failure mortality measure to reflect performance on readmission and death. We believe that it is important to retain these admissions in the measure as opposed to excluding them because they provide a more complete picture of quality of care and resource use, including for individuals at the end of life. Despite the shorter average survival time of 14 days, the readmission rate was higher for these admissions, at 36.9%, compared with the readmission rate of 22.7% for admissions in which the patient survived the full 30 days. Another possible approach to handling the competing outcome of death is to use a composite outcome of readmission or death. However, we believe that it is important to show the outcomes separately because the factors that predict readmission and death may differ and because, from a quality improvement perspective, it would not be possible to assess whether hospital performance was driven by readmission rates or mortality rates if a combined outcome were utilized.
In conclusion, this article presents an instrument to produce hospital-specific risk-standardized estimates of 30-day readmission rates after discharge for heart failure. These estimates can bring to light a perspective on the health systems performance and facilitate tracking of improvement over time.
| Acknowledgments |
|---|
Sources of Funding
Drs Stauffer and Schuur were funded by the Department of Veterans Affairs during the time the work was conducted. The analyses on which this publication is based were performed under contract No. HHSM-500–2005-CO001C, entitled "Utilization and Quality Control Quality Improvement Organization for the State (Commonwealth) of Colorado," funded by the CMS, an agency of the US Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. The authors assume full responsibility for the accuracy and completeness of the ideas presented.
Disclosures
Dr Krumholz reports that he is a consultant to United Healthcare. Dr Normand reports that she is funded by the Massachusetts Department of Public Health to monitor the quality of care after cardiac surgery or percutaneous coronary intervention. The other authors report no conflicts.
| References |
|---|
|
|
|---|
2. Medicare Payment Advisory Commission (MedPAC). Promoting greater efficiency in Medicare. Available at: http://www.medpac.gov/documents/Jun07_EntireReport.pdf. June 2007. Accessed August 29, 2008.
3. Wexler DJ, Chen J, Smith GL, Radford MJ, Yaari S, Bradford WD, Krumholz HM. Predictors of costs of caring for elderly patients discharged with heart failure. Am Heart J. 2001; 142: 350–357.[CrossRef][Medline]
4. Centers for Medicare & Medicaid Services. Medicare ranking for all short-stay hospitals by discharges fiscal year 2005 versus 2004. Available at: http://www.cms.hhs.gov/MedicareFeeforSvcPartsAB/Downloads/SSDischarges0405.pdf. Accessed August 29, 2008.
5. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J. 2004; 25: 1570–1595.
6. Gwadry-Sridhar F, Flintoft V, Lee D, Lee H, Guyatt G. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med. 2004; 164: 2315–2320.
7. Jovicic A, Holroyd-Leduc JM, Straus SE. Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovasc Disord. 2006; 6: 43.[CrossRef][Medline]
8. Koelling T. Multifaceted outpatient support can improve outcomes for people with heart failure: commentary. Evid Based Cardiovasc Med. 2005; 9: 138–141.[CrossRef][Medline]
9. Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA, Radford MJ, Crombie P, Vaccarino V. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002; 39: 83–89.
10. McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001; 110: 378–384.[CrossRef][Medline]
11. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004; 291: 1358–1367.
12. Rich M, Beckham V, Wittenberg C, Leven C, Freedland K, Carney R. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333: 1190–1195.
13. Ross JS, Mulvey G, Stauffer B, Patlolla V, Bernheim SM, Keenan PS, Krumholz HM. Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med. 2008; 168: 1371–1386.
14. National Quality Forum. National Quality Forum endorses consensus standards for quality of hospital care. Available at: http://www.qualityforum.org/news/releases/051508-endorsed-measures.asp. Accessed August 29, 2008.
15. Krumholz HM, Brindis RG, Brush JE, Cohen DJ, Epstein AJ, Furie K, Howard G, Peterson ED, Rathore SS, Smith SC Jr., Spertus JA, Wang Y, Normand S-LT. Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group; cosponsored by the Council on Epidemiology and Prevention and the Stroke Council endorsed by the American College of Cardiology Foundation. Circulation. 2006; 113: 456–462.
16. Centers for Medicare & Medicaid Services. Hospital Compare: a quality tool for adults, including people with Medicare. Available at: http://www.hospitalcompare.hhs.gov. Accessed August 29, 2008.
17. Krumholz HM, Wang Y, Mattera JA, Wang Y-F, Han LF, Ingber MJ, Roman S, Normand SL. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation. 2006; 113: 1693–1701.
18. Krumholz HM, Wang Y, Mattera JA, Wang Y-F, Han LF, Ingber MJ, Roman S, Normand SL. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation. 2006; 113: 1683–1692.
19. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J. 2002; 143: 412–417.[CrossRef][Medline]
20. QualityNet. Condition Category-ICD-9-CM Crosswalk. Available at http://www.qualitynet.org/dcs/ContentServer?cid=1182785083979&pagename=QnetPublic%2FPage%2FQnetTier3&c=Page. Accessed August 29, 2008.
21. Pope GC, Kautter J, Ellis RP, Ash AS, Ayanian JZ, Iezzoni LI, Ingber MJ, Levy JM, Robst J. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev. 2004; 25: 119–141.[Medline]
23. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
24. Daniels MJ, Gatsonis C. Hierarchical generalized linear models in the analysis of variations in health care utilization. J Am Stat Assoc. 1999; 94: 29–42.[CrossRef]
25. Koelling T, Johnson M, Cody R, Aaronson K. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation. 2005; 111: 179–185.
26. Seow H, Phillips CO, Rich MW, Spertus JA, Krumholz HM, Lynn J. Isolation of health services research from practice and policy: the example of chronic heart failure management. J Am Geriatr Soc. 2006; 54: 535–540.[CrossRef][Medline]
27. Philbin EF, DiSalvo TG. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol. 1999; 33: 1560–1566.
28. Yamokoski LM, Hasselblad V, Moser DK, Binanay C, Conway GA, Glotzer JM, Hartman KA, Stevenson LW, Leier CV. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail. 2007; 13: 8–13.[CrossRef][Medline]
29. Fisher E, Wennberg J, Stukel T, Sharp S. Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med. 1994; 331: 989–995.
30. AHA. 2007 Statistical Fact Sheet. Populations: older Americans and cardiovascular disease. Available at: http://www.americanheart.org/downloadable/heart/1168618073572OLDER07.REV.pdf. Accessed August 29, 2008.
| Footnotes |
|---|
Related Article
Circ Cardiovasc Qual Outcomes 2008 1: 9-11.
This article has been cited by other articles:
![]() |
L. Venkitachalam and J. A. Spertus Stepping Outside of the Heart: Using Nontraditional Patient Characteristics to Understand and Improve Outcomes J. Am. Coll. Cardiol., January 26, 2010; 55(4): 317 - 319. [Full Text] [PDF] |
||||
![]() |
J. S. Ross, J. Chen, Z. Lin, H. Bueno, J. P. Curtis, P. S. Keenan, S.-L. T. Normand, G. Schreiner, J. A. Spertus, M. T. Vidan, et al. Recent National Trends in Readmission Rates After Heart Failure Hospitalization Circ Heart Fail, January 1, 2010; 3(1): 97 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, W. C. Levy, and D. L. Veenstra Cost-Consequences of Ultrafiltration for Acute Heart Failure: A Decision Model Analysis Circ Cardiovasc Qual Outcomes, November 1, 2009; 2(6): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz One Year at Circulation: Cardiovascular Quality and Outcomes Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 399 - 401. [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz Medicine in the Era of Outcomes Measurement Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 141 - 143. [Full Text] [PDF] |
||||
![]() |
G. W. Neuberg The Cost of End-of-Life Care: A New Efficiency Measure Falls Short of AHA/ACC Standards Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 127 - 133. [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz Outcomes Research: Myths and Realities Circ Cardiovasc Qual Outcomes, January 1, 2009; 2(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz, P. S. Keenan, J. E. Brush Jr, V. J. Bufalino, M. E. Chernew, A. J. Epstein, P. A. Heidenreich, V. Ho, F. A. Masoudi, D. B. Matchar, et al. Standards for Measures Used for Public Reporting of Efficiency in Health Care: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1518 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz, P. S. Keenan, J. E. Brush Jr, V. J. Bufalino, M. E. Chernew, A. J. Epstein, P. A. Heidenreich, V. Ho, F. A. Masoudi, D. B. Matchar, et al. Standards for Measures Used for Public Reporting of Efficiency in Health Care: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation Circulation, October 28, 2008; 118(18): 1885 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz Circulation: Cardiovascular Quality and Outcomes: Scholarship to Improve Health and Health Care for Patients and Populations Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow Measuring Quality in Heart Failure: Do We Have the Metrics? Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 9 - 11. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |